tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alec Stranahan, 36 are a BUY (55.38%), 14 are a SELL (21.54%), 15 are a HOLD (23.08%).
Analyst Alec Stranahan, currently employed at BAML, carries an average stock price target met ratio of 57.18% that have a potential upside of 34.79% achieved within 163 days.
Alec Stranahan’s has documented 124 price targets and ratings displayed on 17 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CADL, Candel Therapeutics at 14-Aug-2026.
Analyst best performing recommendations are on NXTC (NEXTCURE ).
The best stock recommendation documented was for TGTX (TG THERAPEUTICS) at 5/20/2022. The price target of $5 was fulfilled within 4 days with a profit of $0.39 (7.24%) receiving and performance score of 18.09.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jun-2019
$15
$13.35 (809.09%)
1 years 1 months 28 days ago
(15-Jul-2025)
10/12 (83.33%)
$10.24 (215.13%)
439
Buy Since 08-Aug-2023
$36
1 years 2 months 11 days ago
(01-Jul-2025)
0/3 (0%)
$28.31 (368.14%)
Buy Since 05-Nov-2021
$4
$-5.99 (-59.96%)
$72
2 years 1 months 10 days ago
(02-Aug-2024)
1/4 (25%)
$-15.2 (-79.17%)
249
Buy Since 24-Mar-2020
3 years 10 months 8 days ago
(04-Nov-2022)
2/2 (100%)
$-43.04 (-72.90%)
518
Buy Since 23-Aug-2022
$15
$3.36 (28.87%)
$19
4 years 20 days ago
(23-Aug-2022)
3/3 (100%)
$-38.28 (-71.85%)
469
Which stock is Alec Stranahan most bullish on?
Which stock is Alec Stranahan most reserved on?
What Year was the first public recommendation made by Alec Stranahan?
